Information here is drawn from published research and regulatory documents
Important: Prescription weight loss medications and endoscopic procedures are not appropriate for every patient
This combination approach produces more refined, natural-looking outcomes and allows the practice to address both macro changes (excess skin removal) and micro improvements (skin texture, tone, and firmness) within a cohesive treatment plan
For melanocortin receptor research data see the PT-141 Research Guide
doi: 10.3233/JAD-190156 10 KellarDCraftS
There are also a few cautions the FDA notes specific to this drug, including but not limited to: risk of pancreatitis hypoglycemia (low blood sugar) when used in conjunction with certain other drugs renal impairment or kidney failure acute gallbladder disease increased risk of thyroid C-cell tumors The FDA notes that patients who have had, or have family members who have had, medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use liraglutide, nor should individuals who have experienced prior serious hypersensitivity reaction to the drug